PKCε (85-92)（ψεRACK）是一种多肽和选择性PKCε激活剂，不影响其他PKC同工酶的活性。PKCε (85-92)可诱导内皮细胞的促血管生成反应，促进FGF-2胞吐，调节VEGF活性。

FPA-124是一种细胞可渗透的铜配合物，作为选择性Akt（蛋白激酶B）抑制剂与Akt的同源结构域（PH）和激酶结构域相互作用，诱导细胞凋亡。具有高效的优点，在多种癌细胞系表现出剂量依赖性的生长抑制作用。

BMS-587101 is a small molecule antagonist of LFA-1, which can reduce inflammation and joint destruction in the mouse model of arthritis.

MEK Inhibitor II(2-Chloro-3-(N-succinimidyl)-1,4-naphthoquinone)是一种选择性的MEK1抑制剂(IC50=0.38 μM)，能够抑制克氏锥虫(T. cruzi)微管蛋白聚合(IC50=6 μM)，对锥虫具有抑制活性(IC50=2.77 μM)。

Valrubicin (AD-32) 是一种具有抗炎和抗肿瘤作用的化疗剂，能够抑制 TPA 和 PDBu 诱导的 PKC 活化，IC50值分别为 0.85 和 1.25 μM。

HS-27 是一种荧光束缚的 Hsp90 抑制剂，SNX-5422 通过 PEG 接头束缚在异硫氰酸荧光素或 FITC 上。 HS-27 可用于“即看即治”模式。

SAR125844 是高度选择性可逆ATP 竞争性的MET 受体酪氨酸激酶抑制剂，其IC50值为4.2 nM。能抑制细胞中MET 的自磷酸化。

Palmitic acid-13C is intended for use as an internal standard for the quantification of palmitic acid by GC- or LC-MS. Palmitic acid is a 16-carbon saturated fatty acid. It comprises approximately 25% of human total plasma lipids.1 It increases protein levels of COX-2 in RAW 264.7 cells when used at a concentration of 75 μM.2 Palmitic acid is involved in the acylation of proteins to anchor membrane-bound proteins to the lipid bilayer.2,3,4,5,6 |1. Santos, M.J., López-Jurado, M., Llopis, J., et al. Influence of dietary supplementation with fish oil on plasma fatty acid composition in coronary heart disease patients. Ann. Nutr. Metab. 39(1), 52-62 (1995).|2. Lee, J.Y., Sohn, K.H., Rhee, S.H., et al. Saturated fatty acids, but not unsaturated fatty acids, induced the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J. Biol. Chem. 276(20), 16683-16689 (2001).|3. Dietzen, D.J., Hastings, W.R., and Lublin, D.M. Caveolin is palmitoylated on multiple cysteine residues. Pal

PU-WS13 是一种活性分子，可用于生命科学相关研究，其 CAS 号为 1454619-14-7。